Corteva has underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.
While Corteva has trailed behind the S&P 500 Index over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Company's First Bioinsecticide Helps Protect Apples, Oranges, Wheat, Rice, Corn, Among Other Crops
INDIANAPOLIS , Nov. 4, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the third quarter and nine months ended September 30, 2025....
INDIANAPOLIS , Oct. 31, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.18 cents per share, payable December 15,...
Corteva is all set to release its fiscal third-quarter earnings next month, and analysts project earnings in line with the year-ago quarter.
There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Ecolab (ECL – Research Report) and Corteva (CTVA – Research Report) with bullish sentiments.Elevate Your...
Argus Research analyst Alexandra Yates maintained a Buy rating on Corteva on October 10 and set a price target of $80.00. The company’s shares closed last Friday at $61.83.Elevate Your Investing Strategy:...
These companies have all seen notable interest from analysts that have recently upgraded their ratings, a potential signal of gains ahead.